This invention relates to compounds of the following Formula (I); or a pharmaceutically acceptable salt, solvate, ester or isomer thereof, which is useful for the treatment of diseases or conditions mediated by LpxC.
这项发明涉及以下式(I)的化合物;或其药学上可接受的盐、溶剂合物、
酯或异构体,用于治疗由LpxC介导的疾病或症状。